Gergana Zlateva

Summary

Affiliation: Pfizer Global Research and Development
Country: USA

Publications

  1. pmc Societal and individual burden of illness among fibromyalgia patients in France: association between disease severity and OMERACT core domains
    Serge Perrot
    Service de Médecine Interne et Thérapeutique, Consultation de la douleur, Hotel Dieu Hospital, Universite Paris Descartes, Paris, France
    BMC Musculoskelet Disord 13:22. 2012
  2. pmc The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States
    Caroline Schaefer
    Health Economics and Outcomes Research, Covance Market Access Services Inc, Gaithersburg, MD, USA
    Health Qual Life Outcomes 9:71. 2011
  3. pmc Relationships between changes in pain severity and other patient-reported outcomes: an analysis in patients with posttraumatic peripheral neuropathic pain
    Robert van Seventer
    Pain Clinic, Amphia Hospital, Breda, The Netherlands
    Health Qual Life Outcomes 9:17. 2011
  4. pmc Evaluation of the impact of fibromyalgia on patients' sleep and the content validity of two sleep scales
    Susan Martin
    RTI Health Solutions, 3040 Cornwallis Road, Research Triangle Park, NC, 27709, USA
    Health Qual Life Outcomes 7:64. 2009
  5. pmc Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis
    Usha Chakravarthy
    Centre for Vision Science, Queen s University Belfast, Northern Ireland, UK
    BMC Ophthalmol 10:31. 2010
  6. pmc Newly diagnosed exudative age-related macular degeneration treated with pegaptanib sodium monotherapy in US community-based practices: medical chart review study
    Pamela A Weber
    Pfizer Inc, New York, New York 10017, USA
    BMC Ophthalmol 10:2. 2010
  7. pmc Toward characterization and definition of fibromyalgia severity
    Stuart Silverman
    Cedars Sinai Medical Center, Los Angeles, CA, USA
    BMC Musculoskelet Disord 11:66. 2010
  8. pmc Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis
    Robert M Bennett
    Oregon Health and Science University, Portland, Oregon, USA
    BMC Musculoskelet Disord 11:134. 2010
  9. pmc Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies
    David Semel
    Pfizer Global Pharmaceuticals, New York, NY, USA
    BMC Fam Pract 11:85. 2010
  10. pmc Burden of anemia in patients with osteoarthritis and rheumatoid arthritis in French secondary care
    Gergana Zlateva
    Pfizer Inc, New York, NY, USA
    BMC Geriatr 10:59. 2010

Collaborators

  • Joseph C Cappelleri
  • Alesia B Sadosky
  • Raymond Cheung
  • Birol Emir
  • Caroline Schaefer
  • Serge Perrot
  • Meghan Hufstader
  • Robert van Seventer
  • Andrew G Bushmakin
  • Stuart Silverman
  • Pamela A Weber
  • Robert M Bennett
  • Usha Chakravarthy
  • David Semel
  • Arthi Chandran
  • Susan Martin
  • Tyler Knight
  • Arthi B Chandran
  • Rebecca Baik
  • Don Goldenberg
  • Flemming W Bach
  • Michael Serpell
  • Michael McNett
  • Bart Morlion
  • Meryem Nimour
  • Robert Gerwin
  • Andreas Pleil
  • Astrid Fletcher
  • Jon Russell
  • Xiao Xu
  • Yating Yeh
  • Thomas F Goss
  • Barbara M Wirostko
  • Ronald Buggage
  • T Kevin Murphy
  • Chris Evans
  • Paul Mitchell
  • Tien Y Wong
  • Jose Ma J Alvir
  • Christopher Evans
  • Elisabeth Piault
  • Laurie Zografos

Detail Information

Publications11

  1. pmc Societal and individual burden of illness among fibromyalgia patients in France: association between disease severity and OMERACT core domains
    Serge Perrot
    Service de Médecine Interne et Thérapeutique, Consultation de la douleur, Hotel Dieu Hospital, Universite Paris Descartes, Paris, France
    BMC Musculoskelet Disord 13:22. 2012
    ..This study aimed to provide an assessment of the burden of illness associated with FM in France and its association with disease severity and core domains as defined by Outcome Measures in Rheumatology Clinical Trials (OMERACT) for FM...
  2. pmc The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States
    Caroline Schaefer
    Health Economics and Outcomes Research, Covance Market Access Services Inc, Gaithersburg, MD, USA
    Health Qual Life Outcomes 9:71. 2011
    ..This observational study evaluates the impact of FM severity on patients' symptoms, health-related quality of life (HRQoL), and productivity in the United States...
  3. pmc Relationships between changes in pain severity and other patient-reported outcomes: an analysis in patients with posttraumatic peripheral neuropathic pain
    Robert van Seventer
    Pain Clinic, Amphia Hospital, Breda, The Netherlands
    Health Qual Life Outcomes 9:17. 2011
    ....
  4. pmc Evaluation of the impact of fibromyalgia on patients' sleep and the content validity of two sleep scales
    Susan Martin
    RTI Health Solutions, 3040 Cornwallis Road, Research Triangle Park, NC, 27709, USA
    Health Qual Life Outcomes 7:64. 2009
    ..Therefore, the objective of this study was to evaluate the impact of FM on participants, including their sleep, and to test the content validity of these two sleep measures in FM patients...
  5. pmc Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis
    Usha Chakravarthy
    Centre for Vision Science, Queen s University Belfast, Northern Ireland, UK
    BMC Ophthalmol 10:31. 2010
    ..We aimed to identify those risk factors with strong levels of evidence which could be easily assessed by physicians or ophthalmologists to implement preventive interventions or address current behaviours...
  6. pmc Newly diagnosed exudative age-related macular degeneration treated with pegaptanib sodium monotherapy in US community-based practices: medical chart review study
    Pamela A Weber
    Pfizer Inc, New York, New York 10017, USA
    BMC Ophthalmol 10:2. 2010
    ....
  7. pmc Toward characterization and definition of fibromyalgia severity
    Stuart Silverman
    Cedars Sinai Medical Center, Los Angeles, CA, USA
    BMC Musculoskelet Disord 11:66. 2010
    ..The objective of this study was to evaluate whether patient self-reported severity of FM is associated with severity of pain and sleep interference and the presence of core co-morbidities...
  8. pmc Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis
    Robert M Bennett
    Oregon Health and Science University, Portland, Oregon, USA
    BMC Musculoskelet Disord 11:134. 2010
    ..The purpose of this study was to determine whether some of the clinical features of fibromyalgia (FM) that patients would like to see improved aggregate into definable clusters...
  9. pmc Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies
    David Semel
    Pfizer Global Pharmaceuticals, New York, NY, USA
    BMC Fam Pract 11:85. 2010
    ....
  10. pmc Burden of anemia in patients with osteoarthritis and rheumatoid arthritis in French secondary care
    Gergana Zlateva
    Pfizer Inc, New York, NY, USA
    BMC Geriatr 10:59. 2010
    ..The objective of this study is to investigate associations between health care resource utilization in arthritis patients with and without concomitant anemia in a secondary care setting in France...
  11. doi request reprint Pain responder analysis: use of area under the curve to enhance interpretation of clinical trial results
    Joseph C Cappelleri
    Pfizer Inc, New London, Connecticut 06320, USA
    Pain Pract 9:348-53. 2009
    ..7% (450 mg/day), and 12.5% (600 mg/day) more than placebo responders. This novel approach demonstrates that responder profiles can provide an enhanced interpretation of pain outcomes for patient care and symptom management...